scholarly article | Q13442814 |
P819 | ADS bibcode | 2009PLoSO...4.6986M |
P356 | DOI | 10.1371/JOURNAL.PONE.0006986 |
P932 | PMC publication ID | 2737286 |
P698 | PubMed publication ID | 19750229 |
P5875 | ResearchGate publication ID | 26808305 |
P50 | author | Martin Dreyling | Q23062092 |
Martin-Leo Hansmann | Q23062116 | ||
Felipe Prosper | Q37835050 | ||
José I Martín-Subero | Q39062643 | ||
Claudia Haferlach | Q66370782 | ||
Reiner Siebert | Q78771973 | ||
Monika Brüggemann | Q87941467 | ||
Ole Ammerpohl | Q40927405 | ||
Inga Vater | Q40930641 | ||
Marina Bibikova | Q40930769 | ||
Eliza Wickham-Garcia | Q40930793 | ||
Manuel Montesinos-Rongen | Q40931138 | ||
Lorenz Trümper | Q40931557 | ||
Xabier Agirre | Q40931651 | ||
Ralf Küppers | Q23661843 | ||
P2093 | author name string | Martin J S Dyer | |
Wolfram Klapper | |||
Jian-Bing Fan | |||
Ming Q Du | |||
Sara Alvarez | |||
José Román-Gómez | |||
Juan Cruz Cigudosa | |||
Harald Stein | |||
Christiane Pott | |||
Julia Richter | |||
Marc Seifert | |||
Stefan Gesk | |||
Sylvia Hartmann | |||
Lana Harder | |||
Martina Deckert | |||
Inga Nagel | |||
Jan Dürig | |||
Maria J Calasanz | |||
Javier Suela | |||
Stefanie Bug | |||
P2860 | cites work | DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma | Q37334796 |
Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome | Q38423131 | ||
PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy. | Q40010855 | ||
Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study | Q40019673 | ||
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer | Q40059974 | ||
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia | Q40200349 | ||
Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation | Q40243292 | ||
Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior | Q40245112 | ||
Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia | Q40267029 | ||
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q | Q51578542 | ||
Automatic registration of microarray images. II. Hexagonal grid | Q52008758 | ||
Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. | Q52110894 | ||
Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. | Q53354902 | ||
Methylation profiling in acute myeloid leukemia. | Q53729917 | ||
Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape. | Q54515558 | ||
Gene expression polymorphisms of interleukins-1β, -4, -6, -8, -10, and tumor necrosis factors-α, -β: regression analysis of their effect upon oral squamous cell carcinoma | Q58602111 | ||
Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter | Q79920520 | ||
Hodgkin lymphoma and interleukin-10: shall we go down from the tip of the iceberg? | Q82670237 | ||
Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor | Q40399499 | ||
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. | Q40538231 | ||
GeneVenn - A web application for comparing gene lists using Venn diagrams | Q41908722 | ||
The diagnositc significance of Myf-3 hypermethylation in malignant lymphoproliferative disorders | Q43614250 | ||
Inflammatory cytokine gene polymorphisms in gastric cancer cases' and controls' family members from Chinese areas at high cancer prevalence | Q44041282 | ||
Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. | Q44521103 | ||
Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis | Q45147369 | ||
Highly parallel SNP genotyping | Q46226424 | ||
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer | Q46261945 | ||
Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population. | Q46380357 | ||
Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers | Q46405029 | ||
Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms | Q46761718 | ||
Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction | Q47299700 | ||
Automatic registration of microarray images. I. Rectangular grid | Q47602401 | ||
Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes | Q48075617 | ||
The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study | Q24563021 | ||
DNA methylation profiling of human chromosomes 6, 20 and 22 | Q24607522 | ||
Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma | Q24653663 | ||
Control of developmental regulators by Polycomb in human embryonic stem cells | Q28235841 | ||
The epigenomics of cancer | Q28289975 | ||
Epigenetics in cancer | Q29547853 | ||
The mammalian epigenome | Q29615763 | ||
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome | Q29616819 | ||
Epigenetic stem cell signature in cancer | Q29622897 | ||
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 | ||
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
An integrative genomic and epigenomic approach for the study of transcriptional regulation | Q33325492 | ||
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling | Q33392210 | ||
The role of chromosome translocations in leukemogenesis. | Q33793085 | ||
Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation | Q33945892 | ||
The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies | Q33980478 | ||
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features. | Q34156717 | ||
Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers | Q34170525 | ||
Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers | Q34399906 | ||
High-throughput DNA methylation profiling using universal bead arrays | Q34483135 | ||
DNA methylation in cancer: too much, but also too little | Q34770545 | ||
Demethylating agents in myeloid malignancies | Q34847863 | ||
Role of epigenetic changes in hematological malignancies | Q35738478 | ||
Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis | Q36076356 | ||
The fundamental role of epigenetics in hematopoietic malignancies | Q36373780 | ||
Cytosine methylation profiling of cancer cell lines. | Q36534546 | ||
Gene silencing by DNA methylation in haematological malignancies | Q36816162 | ||
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. | Q37086937 | ||
DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status | Q37124632 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | DNA methylation | Q874745 |
P304 | page(s) | e6986 | |
P577 | publication date | 2009-09-11 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms | |
P478 | volume | 4 |
Q38403894 | A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia |
Q41979413 | A genome-wide methylation study of severe vitamin D deficiency in African American adolescents |
Q42583748 | Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms. |
Q28728960 | Cancer: evolutionary, genetic and epigenetic aspects |
Q33584274 | Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features |
Q39139055 | CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors |
Q39016336 | Current Trends and Alternative Scenarios in EBV Research |
Q38237444 | DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist |
Q36380887 | DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis |
Q36187834 | DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status |
Q33680945 | DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia |
Q34505483 | DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia |
Q58596681 | DNA methylation profiling identifies candidate genes for the pathogenesis of hepatosplenic T-cell lymphoma |
Q35874941 | DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients |
Q35129383 | DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia |
Q34314087 | DNA-methylation profiling of fetal tissues reveals marked epigenetic differences between chorionic and amniotic samples |
Q98513625 | Decreased expression of the thyroid hormone-inactivating enzyme type 3 deiodinase is associated with lower survival rates in breast cancer |
Q28249351 | Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma |
Q57569019 | Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma |
Q39515650 | Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype. |
Q38667123 | Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases |
Q40539026 | Epigenetic Heterogeneity of B-Cell Lymphoma: DNA Methylation, Gene Expression and Chromatin States |
Q33954847 | Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications. |
Q38286091 | Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma |
Q85039307 | Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma |
Q35050525 | Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis |
Q38844664 | Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers |
Q40525719 | Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia. |
Q37965026 | Epigenetic regulation of miRNA genes in acute leukemia. |
Q42181337 | Epstein-Barr virus-host cell interactions: an epigenetic dialog? |
Q33840913 | Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia |
Q39617678 | Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia. |
Q92114210 | Genome-wide DNA methylation analysis of colorectal adenomas with and without recurrence reveals an association between cytosine-phosphate-guanine methylation and histological subtypes |
Q36100977 | Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia |
Q33712031 | Genome-wide DNA methylation maps in follicular lymphoma cells determined by methylation-enriched bisulfite sequencing |
Q35878552 | Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact |
Q39141229 | Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features. |
Q44097865 | Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes. |
Q36831907 | Genomic imprinting of the type 3 thyroid hormone deiodinase gene: regulation and developmental implications |
Q40200164 | Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms |
Q33690545 | Heparan sulfate 3-O-sulfation: a rare modification in search of a function. |
Q34181789 | Identification of Driver and Passenger DNA Methylation in Cancer by Epigenomic Analysis |
Q34347248 | Immortalization of T-cells is accompanied by gradual changes in CpG methylation resulting in a profile resembling a subset of T-cell leukemias. |
Q33562640 | Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens |
Q49447563 | Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer |
Q40016309 | Increased incidence of aberrant DNA methylation within diverse imprinted gene loci outside of IGF2/H19 in Silver-Russell syndrome |
Q58010765 | Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma |
Q46530451 | Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling |
Q49874623 | Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma. |
Q35029454 | Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells |
Q39388451 | Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia |
Q34480513 | Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis |
Q34750551 | Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma |
Q35208036 | Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance |
Q47662300 | Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia |
Q37637014 | Next generation sequencing: advances in characterizing the methylome |
Q38497307 | Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women. |
Q92542001 | Precision Medicine in Lymphoma by Innovative Instrumental Platforms |
Q34769855 | Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia |
Q38232195 | Role of epigenetics in EBV regulation and pathogenesis |
Q44483899 | Safe and effective medicines for all: is personalized medicine the answer? |
Q42881035 | Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma |
Q35960563 | TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells. |
Q35983746 | TET1 is a tumor suppressor of hematopoietic malignancy |
Q93090953 | The Emerging Roles of Heparan Sulfate 3-O-Sulfotransferases in Cancer |
Q36724810 | The Impact of DNA Methylation in Hematopoietic Malignancies |
Q36594150 | The epigenetic landscape of oral squamous cell carcinoma |
Q38482642 | The peripheral whole-blood transcriptome of acute pyelonephritis in human pregnancya |
Q84443544 | The promises of personalized medicine |
Q38984303 | The tissue is the issue: improved methylome analysis from paraffin-embedded tissues by application of the HOPE technique |
Q37772500 | Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference. |
Q40115928 | Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines |